Randy Sweis to Receptor, Fibroblast Growth Factor, Type 3
This is a "connection" page, showing publications Randy Sweis has written about Receptor, Fibroblast Growth Factor, Type 3.
Connection Strength
0.937
-
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer. Front Immunol. 2020; 11:575258.
Score: 0.743
-
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Cancer Immunol Res. 2016 07; 4(7):563-8.
Score: 0.136
-
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model. Front Immunol. 2024; 15:1358019.
Score: 0.058